Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.
Scientists looked at multiple techniques used to measure the modified viruses deployed in some gene therapy research and treatments. One technique, known as SEC-MALS, was the most precise and accurate ...
ABL Biomanufacturing - a pure play Contract Development and Manufacturing Organisation (CDMO) that specialises in the development and manufacturing of gene therapies, oncolytic viruses ...
Their study included two VIGE strategies — one with tobacco rattle virus (TRV) vector delivering single guide RNAs (sgRNAs) into a transgenic tomato line expressing Cas9 gene, and the second ...